These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Ventricular function and Na+,K(+)-ATPase activity and distribution with chronic supraventricular tachycardia. Spinale FG; Pearce AP; Schulte BA; Crawford FA Cardiovasc Res; 1991 Feb; 25(2):138-44. PubMed ID: 1660347 [TBL] [Abstract][Full Text] [Related]
3. Changes in left ventricular volume, mass, and function during the development and regression of supraventricular tachycardia-induced cardiomyopathy. Disparity between recovery of systolic versus diastolic function. Tomita M; Spinale FG; Crawford FA; Zile MR Circulation; 1991 Feb; 83(2):635-44. PubMed ID: 1991381 [TBL] [Abstract][Full Text] [Related]
4. The cellular basis for the blunted response to beta-adrenergic stimulation in supraventricular tachycardia-induced cardiomyopathy. Tanaka R; Fulbright BM; Mukherjee R; Burchell SA; Crawford FA; Zile MR; Spinale FG J Mol Cell Cardiol; 1993 Oct; 25(10):1215-33. PubMed ID: 8263955 [TBL] [Abstract][Full Text] [Related]
5. Direct effects of chronic beta-adrenergic receptor blockade on left ventricular and myocyte function in a model of tachycardia-induced congestive heart failure. Spinale FG; Johnson WS; Wang Y; Wang Z; Mukherjee R; Hebbar L; Jones BU J Card Fail; 1996 Dec; 2(4):311-8. PubMed ID: 8989646 [TBL] [Abstract][Full Text] [Related]
6. Relation between ventricular and myocyte function with tachycardia-induced cardiomyopathy. Spinale FG; Fulbright BM; Mukherjee R; Tanaka R; Hu J; Crawford FA; Zile MR Circ Res; 1992 Jul; 71(1):174-87. PubMed ID: 1606661 [TBL] [Abstract][Full Text] [Related]
7. Effects of chronic tachycardia-induced cardiomyopathy on the beta-adrenergic receptor system. Burchell SA; Spinale FG; Crawford FA; Tanaka R; Zile MR J Thorac Cardiovasc Surg; 1992 Oct; 104(4):1006-12. PubMed ID: 1328769 [TBL] [Abstract][Full Text] [Related]
8. Relation between ventricular and myocyte remodeling with the development and regression of supraventricular tachycardia-induced cardiomyopathy. Spinale FG; Zellner JL; Tomita M; Crawford FA; Zile MR Circ Res; 1991 Oct; 69(4):1058-67. PubMed ID: 1934334 [TBL] [Abstract][Full Text] [Related]
9. Reduced 3H-ouabain binding site (Na,K-ATPase) concentration in ventricular myocardium of dogs with tachycardia induced heart failure. Schmidt TA; Larsen JS; Shannon RP; Komamura K; Vatner DE; Kjeldsen K Basic Res Cardiol; 1993; 88(6):607-20. PubMed ID: 8147825 [TBL] [Abstract][Full Text] [Related]
10. Alterations in myocyte shape and basement membrane attachment with tachycardia-induced heart failure. Zellner JL; Spinale FG; Eble DM; Hewett KW; Crawford FA Circ Res; 1991 Sep; 69(3):590-600. PubMed ID: 1873861 [TBL] [Abstract][Full Text] [Related]
11. Changes in myocardial blood flow during development of and recovery from tachycardia-induced cardiomyopathy. Spinale FG; Tanaka R; Crawford FA; Zile MR Circulation; 1992 Feb; 85(2):717-29. PubMed ID: 1735164 [TBL] [Abstract][Full Text] [Related]
12. Myocyte electrophysiological properties following the development of supraventricular tachycardia-induced cardiomyopathy. Mukherjee R; Hewett KW; Spinale FG J Mol Cell Cardiol; 1995 Jun; 27(6):1333-48. PubMed ID: 8531216 [TBL] [Abstract][Full Text] [Related]
13. Digitalis structure-activity relationship analyses. Conclusions from indirect binding studies with cardiac (Na+ + K+)-ATPase. Brown L; Erdmann E; Thomas R Biochem Pharmacol; 1983 Sep; 32(18):2767-74. PubMed ID: 6313008 [TBL] [Abstract][Full Text] [Related]
14. Quantification of the total Na,K-ATPase concentration in atria and ventricles from mammalian species by measuring 3H-ouabain binding to intact myocardial samples. Stability to short term ischemia reperfusion. Schmidt TA; Svendsen JH; Haunsø S; Kjeldsen K Basic Res Cardiol; 1990; 85(4):411-27. PubMed ID: 2173546 [TBL] [Abstract][Full Text] [Related]
15. Reduced sodium pump alpha1, alpha3, and beta1-isoform protein levels and Na+,K+-ATPase activity but unchanged Na+-Ca2+ exchanger protein levels in human heart failure. Schwinger RH; Wang J; Frank K; Müller-Ehmsen J; Brixius K; McDonough AA; Erdmann E Circulation; 1999 Apr; 99(16):2105-12. PubMed ID: 10217649 [TBL] [Abstract][Full Text] [Related]
16. Alterations in the myocardial capillary vasculature accompany tachycardia-induced cardiomyopathy. Spinale FG; Grine RC; Tempel GE; Crawford FA; Zile MR Basic Res Cardiol; 1992; 87(1):65-79. PubMed ID: 1567354 [TBL] [Abstract][Full Text] [Related]
17. Enhancement of cardiac actions of ouabain and its binding to Na+, K+-adenosine triphosphatase by increased sodium influx in isolated guinea-pig heart. Temma K; Akera T J Pharmacol Exp Ther; 1982 Nov; 223(2):490-6. PubMed ID: 6290640 [TBL] [Abstract][Full Text] [Related]
18. Isoform-specific stimulation of cardiac Na/K pumps by nanomolar concentrations of glycosides. Gao J; Wymore RS; Wang Y; Gaudette GR; Krukenkamp IB; Cohen IS; Mathias RT J Gen Physiol; 2002 Apr; 119(4):297-312. PubMed ID: 11929882 [TBL] [Abstract][Full Text] [Related]
19. Cellular and extracellular remodeling with the development and recovery from tachycardia-induced cardiomyopathy: changes in fibrillar collagen, myocyte adhesion capacity and proteoglycans. Spinale FG; Zellner JL; Johnson WS; Eble DM; Munyer PD J Mol Cell Cardiol; 1996 Aug; 28(8):1591-608. PubMed ID: 8877770 [TBL] [Abstract][Full Text] [Related]
20. Collagen remodeling and changes in LV function during development and recovery from supraventricular tachycardia. Spinale FG; Tomita M; Zellner JL; Cook JC; Crawford FA; Zile MR Am J Physiol; 1991 Aug; 261(2 Pt 2):H308-18. PubMed ID: 1877659 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]